Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Timothy J Shea


Timothy J Shea

Sterne, Kessler, Goldstein & Fox P.L.L.C., USA

Biography

Timothy J Shea is Director of the Biotechnology/Chemical Practice Group at Sterne, Kessler, Goldstein & Fox P.L.L.C., where he has practiced for 20 years. He specializes in advising biopharmaceutical companies and research institutions on complex legal issues relating to the protection, enforcement and transfer of their intellectual property. He practices primarily in the fields of immunology, molecular biology, genetic and medical diagnostics, biotherapeutics, and drug delivery. He has extensive experience advising clients on the creation and management of strategic patent portfolios, freedom-to-operate and patentability issues, complex prosecution strategies, validity and infringement issues, and due diligence investigations in connection with acquisitions and investments. He has published and spoken extensively on IP issues related to therapeutic antibodies and biosimilars. In addition, a significant portion of his practice involves counseling emerging companies on strategies for creating, protecting and leveraging their IP assets to grow their businesses. He received his BS in Biology from Washington and Lee University in 1988 and his JD from Chicago-Kent College of Law (with High Honors, Order of the Coif) in 1995. He served as a judicial extern to the Honorable Rebecca Pallmeyer of the U.S. District Court for the Northern District of Illinois. Prior to attending law school, he worked for several years in the biotech industry in the areas of genetic diagnostics.

Abstract

Abstract : US biosimilars taking flight: Discussion of the key events and cases shaping the US biosimilar landscape